Core Points - The company announced its 2025 interim profit distribution plan, proposing a cash dividend of 0.26 yuan per 10 shares, totaling 20,066,020 yuan, which represents 24.25% of the net profit attributable to shareholders for the first half of 2025 [5][23][30] - The company held its sixth board meeting on August 26, 2025, where the interim report and profit distribution plan were approved unanimously by the board members [4][5][21] - The company will hold its first extraordinary general meeting of 2025 on September 16, 2025, to discuss the approved proposals [50][51] Company Overview - Shanghai Xinpeng Industrial Co., Ltd. has not experienced any changes in its controlling shareholder or actual controller during the reporting period [3] - The company reported a net profit of 82,755,133.51 yuan for the first half of 2025, with a parent company net loss of 1,940,182.34 yuan [5][30] - The total number of shares as of June 30, 2025, is 771,770,000 [5][30] Financial Data - The company’s available profit for distribution to shareholders at the end of the reporting period is 497,834,768.46 yuan [5][30] - The company’s total profit available for distribution, including unallocated profits, is 1,418,729,452.32 yuan [30] Governance and Compliance - The company revised its articles of association and several management systems to align with the new Company Law and regulatory requirements [7][47] - The board of directors has proposed to reappoint Lixin Certified Public Accountants as the financial auditing firm for the year 2025, pending approval at the upcoming extraordinary general meeting [13][36][44]

Group 1 - The company held its 16th meeting of the 5th Board of Directors on August 26, 2025, with all 5 directors present, complying with relevant laws and regulations [3][4][6] - The meeting approved the 2025 semi-annual report and its summary, which will be disclosed on the Shanghai Stock Exchange [4][7] - The meeting also approved a special report on the storage and actual use of raised funds for the first half of 2025, which will be disclosed on the Shanghai Stock Exchange [7][8] Group 2 - The Board approved a proposal to abolish the Supervisory Board and amend the Articles of Association, transferring the powers of the Supervisory Board to the Audit Committee of the Board [9][10] - This proposal requires approval from the shareholders' meeting [11][27] - The Board also approved the revision and formulation of certain management systems, with some requiring shareholder approval [12][14] Group 3 - The company announced the date and details for the 2025 First Extraordinary General Meeting of Shareholders, scheduled for September 11, 2025 [31][33] - The meeting will adopt a combination of on-site and online voting methods [33][34] - Shareholders must register to attend the meeting, with specific registration details provided [39][40] Group 4 - The company reported on the actual use of raised funds, indicating that the total amount raised from the issuance of convertible bonds was approximately RMB 520 million, with a net amount of about RMB 512.7 million after expenses [45][46] - As of June 30, 2025, the company has implemented various projects funded by these raised funds, including a project for the production of pharmaceutical raw materials [49][50] - The company has established a management system for raised funds, ensuring compliance with relevant regulations [46][47]